Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dainippon Sumitomo Pharma of Japan acquiring US drug maker Sepracor for $2.6 billion
Yahoo/AP
Thursday, September 3, 2009 - 8:15am
tags:
Dainippon Sumitomo, Sepracor, buyouts
Roche Drug Shrinks Tumors in Study
WSJ Online
Wednesday, September 2, 2009 - 6:54pm
tags:
Roche, skin cancer, Genentech
Abbott Labs to acquire Visiogen for $400 million
Marketwatch
Wednesday, September 2, 2009 - 4:43pm
tags:
Abbott Laboratories, Visiogen, vision care, M&A
Pfizer's Big News. Or Is It?
CNBC
Wednesday, September 2, 2009 - 4:43pm
tags:
Pfizer, Wyeth, Bextra, settlements
On the Radar: Five biotech companies to watch
Fierce Biotech
Wednesday, September 2, 2009 - 4:40pm
tags:
Rigel, Poniard, OncoGenex, MannKind, GTx, biotech
Good News for Novavax
Yahoo/Zacks.com
Wednesday, September 2, 2009 - 4:27pm
tags:
Novavax, vaccines, AstraZeneca, GSK, Flu
La Jolla Is Too Much of a Gamble Right Now
Seeking Alpha
Wednesday, September 2, 2009 - 10:41am
tags:
La Jolla Pharmaceutical, Cell Genesys
Short Interest in BioDelivery Sciences Is Good News
Seeking Alpha
Wednesday, September 2, 2009 - 10:41am
tags:
BioDelivery Sciences
Did Lexapro's success depend on doc payments?
Fierce Pharma
Wednesday, September 2, 2009 - 10:24am
tags:
Lexapro, physician payments, Forest Labs
Catalyst Pharma bags rights to commercialise new class of GABA inhibitors
Pharmabiz
Wednesday, September 2, 2009 - 10:06am
tags:
GABA inhibitors, Catalyst
CombiMatrix: Full Array of Pending Catalysts
Seeking Alpha
Wednesday, September 2, 2009 - 10:04am
tags:
CombiMatrix
Pfizer may pay $525 mln for Brazil drugmaker-report
Reuters
Wednesday, September 2, 2009 - 10:02am
tags:
Pfizer, Brazil, Neo Quimica, M&A
Mylan, Inc. Lags Behind Drugs - Generic Industry; MYL, PRX, WPI
Learning Markets
Wednesday, September 2, 2009 - 9:45am
tags:
Mylan, generics, Watson Pharmaceuticals, Par Pharmaceutical
Antigenics May Finally Be Back on the Uptick
Seeking Alpha
Wednesday, September 2, 2009 - 9:43am
tags:
Antigenics
Who wins, who loses with biogenerics
Marketwatch
Wednesday, September 2, 2009 - 9:41am
tags:
biogenerics, Neupogen, Amgen, Betaseron, Bayer, Humulin, Eli Lilly, Novolin, Novo Nordisk, Pulmozyme, Roche, Intron A, Infergen, Three Rivers Pharmaceuticals
FDA Panel to Review Allos Cancer Drug
TheStreet.com
Wednesday, September 2, 2009 - 9:37am
tags:
FDA, cancer, Allos
Repros Therapeutics: Circling the Drain to Zero
Seeking Alpha
Wednesday, September 2, 2009 - 9:36am
tags:
Repros Therapeutics
Middlebrook Pharma pares sales force
Fierce Pharma
Wednesday, September 2, 2009 - 9:35am
tags:
Middlebrook, layoffs
Pfizer to pay record $2.3 billion settlement for illegal drug promotion
Yahoo/AP
Wednesday, September 2, 2009 - 9:30am
tags:
Pfizer, settlements, Bextra
Drugmakers Launch Generic Imitrex
FDA News
Tuesday, September 1, 2009 - 5:55pm
tags:
generics, Imitrex, migraines, GSK, Mylan, Sandoz, Dr Reddy's, Roxane Laboratories, Cobalt Laboratories, Orchid Healthcare, Aurobindo, Sun Pharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.